Enzo Biochem, Inc.

NYSE:ENZ   3:15:27 PM EDT
1.97
-0.13 (-6.19%)
Earnings Announcements

Enzo Biochem Q4 GAAP Loss Per Share $0.07

Published: 10/13/2020 20:16 GMT
Enzo Biochem Inc (ENZ) - Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update.
Q4 GAAP Loss per Share $0.07.
Q4 Revenue $19.5 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.